Magnetic resonance imaging

Neural Propulsion Systems (NPS) Showcases Unparalleled Sensor Safety Performance at CES 2024

Retrieved on: 
Wednesday, January 10, 2024
Lidar, Weather, NHTSA, Hertz, Naval Air Systems Command, Research, Semiconductor, MRI, LAS, Mathematics, Texas Instruments, Plague, Computing, Radar, Pedestrian, Algorithm, Glasses, ADAS, Environment, Software, General Motors, Tree, Safety, Electrical engineering, Magnetic resonance imaging, CES, Airport, AEB, Machine learning, Commander, NPS

LAS VEGAS and PLEASANTON, Calif., Jan. 10, 2024 /PRNewswire/ -- Neural Propulsion Systems (NPS), a software platform company offering ultra-resolution imaging radar to support automotive vision sensing, used CES 2024 to showcase a demonstration of the ability to detect pedestrians and complex traffic situations with industry-leading clarity.

Key Points: 
  • Our technology is akin to improving automotive imaging from 20/20 vision to better than 20/10 vision."
  • The CES presentation shows the performance of an automotive radar system based on latest available Texas Instruments 77 GHz chipsets in A versus B testing with and without NPS technology.
  • It also significantly increases reliability by reducing the false positives that plague conventional automotive radar by over ten times.
  • "Chipmakers could use NPS to achieve ultra-resolution performance in real time, more than nine times beyond current systems," said Rezvani.

Introduction of Breast Imaging Legislation Will Benefit Thousands of New Hampshire Residents

Retrieved on: 
Tuesday, January 9, 2024
Woman, Patient, Legislation, MRI, Survival, Google Images, Breast cancer, Disease, Breast MRI, Magnetic resonance imaging, Biopsy, Medical imaging

CONCORD, N.H., Jan. 9, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, commends Representative Catherine Rombeau (D-Bedford) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • In New Hampshire, nearly 1,400 people were diagnosed with breast cancer and 180 died of the disease in 2023 alone.
  • "We know that early detection of breast cancer saves lives, yet too many patients in New Hampshire are forced to put off diagnostic imaging due to cost concerns.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.

Introduction of Breast Imaging Legislation Will Benefit Thousands of Vermonters

Retrieved on: 
Tuesday, January 9, 2024
Woman, Patient, MRI, Vermont House, Google Images, Breast cancer, Cancer, Disease, Breast MRI, Magnetic resonance imaging, Diagnosis, Biopsy, Medical imaging

MONTPELIER, Vt., Jan. 9, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, commends Representative Melanie Carpenter (D-Hyde Park) and Representative Laura Sibilia (I-Dover) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • The exorbitant out-of-pocket costs associated with essential breast imaging procedures ranging from hundreds-to-thousands of dollars, often force individuals into the difficult decision of skipping these tests or making significant financial sacrifices.
  • "Diagnostic breast imaging is an important tool in detecting cancer and should be available to all Vermonters who need it.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.

Introduction of Breast Imaging Legislation Will Benefit Thousands of Floridians

Retrieved on: 
Tuesday, January 9, 2024
Woman, Patient, Legislation, MRI, Food, HB, Google Images, Breast cancer, Disease, Breast MRI, Magnetic resonance imaging, Biopsy, Medical imaging

TALLAHASSEE, Fla., Jan. 9, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, commends Representative Marie Woodson (D-Pembroke Pines) and Senator Lori Berman (D-Boynton Beach) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • In 2023 alone, more than 22,670 individuals were diagnosed with breast cancer and approximately 3,170 died of the disease in Florida.
  • "Many Floridians in need of diagnostic and supplemental breast exams for the early detection of breast cancer are subjected to out-of-pocket costs that are simply unaffordable," said Senator Berman.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.

Introduction of Breast Imaging Legislation Will Benefit Thousands of Virginians

Retrieved on: 
Tuesday, January 9, 2024
Woman, Patient, Legislation, MRI, Health, HB, Google Images, Breast cancer, Map, Cancer, Prognosis, Disease, Breast MRI, Magnetic resonance imaging, Biopsy, Diagnosis, Medical imaging

RICHMOND, Va., Jan. 9, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, commends Delegate Shelly Simonds (D-Newport News) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • In Virginia, 7,810 women were diagnosed with breast cancer in 2023 and 1,150 died of the disease.
  • HB 230 , introduced by Delegate Simonds, eliminates the patient out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging including MRIs, ultrasounds and diagnostic mammograms.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.

3D Imaging Market worth $88.4 billion by 2028- Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 9, 2024
Lidar, 3D, Architecture, Research, Video, Partnership, XR, Autodesk, Depth perception, NTU, ADAS, Environment, Software, Panasonic, MEA, Acquisition, University of Wisconsin–Madison, Safety, Nanyang Technological University, Animation, Quality control, Virtual reality, University, Health, VR, Magnetic resonance imaging, Research and development, Mergers and acquisitions, Comprehension, Engineering, Diagnosis, GE HealthCare, 3D printing

By elevating safety measures, improving maintenance efficiency, and offering engaging customer interactions, 3D imaging reshapes the automotive landscape toward safer, more efficient, and consumer-centric advancements.

Key Points: 
  • By elevating safety measures, improving maintenance efficiency, and offering engaging customer interactions, 3D imaging reshapes the automotive landscape toward safer, more efficient, and consumer-centric advancements.
  • The surging demand for real-time 3D solutions across diverse industries drives the emergence of 3D services tailored for medical imaging, scanning, architectural design, and animation in movies.
  • These services are integral, offering product upgrades, maintenance, training, and consulting, vital in leveraging 3D imaging effectively.
  • Compared to conventional 2D imaging, 3D imaging offers a more accurate and realistic portrayal of objects, sceneries, or settings.

3D Imaging Market worth $88.4 billion by 2028- Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 9, 2024
Lidar, 3D, Architecture, Research, Video, Partnership, XR, Autodesk, Depth perception, NTU, ADAS, Environment, Software, Panasonic, MEA, Acquisition, University of Wisconsin–Madison, Safety, Nanyang Technological University, Animation, Quality control, Virtual reality, University, Health, VR, Magnetic resonance imaging, Research and development, Mergers and acquisitions, Comprehension, Engineering, Diagnosis, GE HealthCare, 3D printing

By elevating safety measures, improving maintenance efficiency, and offering engaging customer interactions, 3D imaging reshapes the automotive landscape toward safer, more efficient, and consumer-centric advancements.

Key Points: 
  • By elevating safety measures, improving maintenance efficiency, and offering engaging customer interactions, 3D imaging reshapes the automotive landscape toward safer, more efficient, and consumer-centric advancements.
  • The surging demand for real-time 3D solutions across diverse industries drives the emergence of 3D services tailored for medical imaging, scanning, architectural design, and animation in movies.
  • These services are integral, offering product upgrades, maintenance, training, and consulting, vital in leveraging 3D imaging effectively.
  • Compared to conventional 2D imaging, 3D imaging offers a more accurate and realistic portrayal of objects, sceneries, or settings.

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

Retrieved on: 
Tuesday, January 9, 2024
Medical Subject Headings, Hip, Marketing, European Commission, Shoulder, MRI, INN, Fatigue, Movement, Dopamine, ATC, Allergy, International, European, Headache, Disease, Weakness, Syndrome, Nausea, Language, Brain, Somnolence, Dizziness, L-DOPA, Ropinirole, Restless legs syndrome, Abdomen, Red, Parkinson's disease, Thigh, Select, Committee, Patient, Cell, Time, Pramipexole, Anatomy, Medicine, Vomiting, IIA, Magnetic resonance imaging, CHMP, Skin, Pharmaceutical industry

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

EQS-News: Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Retrieved on: 
Friday, January 5, 2024
Janus, Biotechnology, Conference, MRI, Serum, Histology, Regeneration, PMS, Multiple sclerosis, Woman, Disease, Calcium, Clinical trial, Investment, AFL, SIRT6, Medicinal chemistry, Ulcerative colitis, Biomarker, Journal of Medicinal Chemistry, DHODH, Patient, Journal, RMS, Magnetic resonance imaging, Pharmaceutical industry

“With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.

Key Points: 
  • “With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.
  • A more thorough review of recent events and upcoming milestones follows:
    Announced a three-tranche private placement of up to $240 million with participation from select new and existing investors today.
  • Immunic believes that this data illustrates biomarker evidence that vidofludimus calcium’s activity extends beyond the previously observed anti-inflammatory effects, further reinforcing its neuroprotective potential.
  • Immunic believes this data provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Retrieved on: 
Friday, January 5, 2024
Janus, Biotechnology, Conference, MRI, Serum, Histology, Regeneration, Entire, PMS, Multiple sclerosis, Woman, Disease, Sirtuin 6, Calcium, Clinical trial, Investment, AFL, SIRT6, Medicinal chemistry, Ulcerative colitis, Biomarker, Journal of Medicinal Chemistry, DHODH, Patient, Journal, RMS, Magnetic resonance imaging, Pharmaceutical industry

"With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.

Key Points: 
  • "With vidofludimus calcium (IMU-838) and IMU-856, we have two development programs beyond clinical proof-of-concept which is an outstanding achievement of our entire team.
  • A more thorough review of recent events and upcoming milestones follows:
    Announced a three-tranche private placement of up to $240 million with participation from select new and existing investors today.
  • Immunic believes that this data illustrates biomarker evidence that vidofludimus calcium's activity extends beyond the previously observed anti-inflammatory effects, further reinforcing its neuroprotective potential.
  • Immunic believes this data provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.